Becker's Healthcare April 26, 2024
In the first three months of 2024, the U.S. reached a record with 323 ongoing medication shortages — the highest number since 2001.
Of the 20 most commonly used therapies, 10 are in short supply.
Here are 11 new shortages, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.
Editor’s note: The drugs are listed in alphabetical order.
Becaplermin topical gel: There are no presentations of the diabetic neuropathic ulcer treatment. Pharmaceutical company Smith & Nephew did not provide a reason for the shortage or a release date.
Cisatracurium besylate injection: AbbVie and Pfizer’s Hospira have discontinued three solutions each of the muscle relaxant. Neither drugmaker listed a reason.
Today's Sponsors
Today's Sponsor